[(2R,3R,4R,5R,6S)-3-hydroxy-4,5,6-tris[(3,4,5-trihydroxybenzoyl)oxy]tetrahydropyran-2-yl]methyl 3,4,5-trihydroxybenzoate

ID: ALA5277868

Max Phase: Preclinical

Molecular Formula: C34H28O22

Molecular Weight: 788.58

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1O)c1cc(O)c(O)c(O)c1

Standard InChI:  InChI=1S/C34H28O22/c35-14-1-10(2-15(36)23(14)43)30(48)52-9-22-27(47)28(54-31(49)11-3-16(37)24(44)17(38)4-11)29(55-32(50)12-5-18(39)25(45)19(40)6-12)34(53-22)56-33(51)13-7-20(41)26(46)21(42)8-13/h1-8,22,27-29,34-47H,9H2/t22-,27-,28-,29-,34+/m1/s1

Standard InChI Key:  RATQVALKDAUZBW-UGUGPVJNSA-N

Molfile:  

 
     RDKit          2D

 56 60  0  0  0  0  0  0  0  0999 V2000
   -0.3570    1.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.2041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3586   -0.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0726    0.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0726    1.0306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3569    1.4424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7848    1.4437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7848    2.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4986    2.6815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4986    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2100    3.9175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9273    3.5057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9273    2.6851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2163    2.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6420    2.2734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6387    3.9188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2100    4.7422    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0701    2.6800    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7882   -0.2060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7882   -1.0307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5028   -1.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2168   -1.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9298   -1.4405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9298   -2.2655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2203   -2.6779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5028   -2.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2203   -3.5026    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6444   -2.6771    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6427   -1.0274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0743   -1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3586   -1.0323    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3542   -1.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3542   -2.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3611   -2.6820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3611   -3.5043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3528   -3.9175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0647   -3.5093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0647   -2.6851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7785   -3.9224    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3528   -4.7422    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0759   -3.9159    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0689   -1.0338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700   -0.2089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0717    1.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0717    2.2655    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7872    2.6771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7872    3.5018    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    2.2640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    1.4392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2124    1.0280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9297    1.4398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9297    2.2604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2187    2.6774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6444    2.6720    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6411    1.0266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2124    0.2033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  5  7  1  1
  7  8  1  0
  8  9  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
  9 14  1  0
 13 15  1  0
 12 16  1  0
 11 17  1  0
  8 18  2  0
  4 19  1  6
 19 20  1  0
 20 21  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 21 26  1  0
 25 27  1  0
 24 28  1  0
 23 29  1  0
 20 30  2  0
  3 31  1  6
 31 32  1  0
 32 33  1  0
 34 33  2  0
 35 34  1  0
 36 35  2  0
 37 36  1  0
 38 37  2  0
 33 38  1  0
 37 39  1  0
 36 40  1  0
 35 41  1  0
 32 42  2  0
  2 43  1  6
  1 44  1  1
 44 45  1  0
 45 46  1  0
 46 47  2  0
 46 48  1  0
 49 48  2  0
 50 49  1  0
 51 50  2  0
 52 51  1  0
 53 52  2  0
 48 53  1  0
 52 54  1  0
 51 55  1  0
 50 56  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5277868

    ---

Associated Targets(non-human)

SARS-CoV (424 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero C1008 (1716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
S Spike glycoprotein (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 788.58Molecular Weight (Monoisotopic): 788.1072AlogP: 0.70#Rotatable Bonds: 9
Polar Surface Area: 377.42Molecular Species: NEUTRALHBA: 22HBD: 13
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.55CX Basic pKa: CX LogP: 3.41CX LogD: 3.11
Aromatic Rings: 4Heavy Atoms: 56QED Weighted: 0.06Np Likeness Score: 0.85

References

1. Shagufta, Ahmad I..  (2021)  The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.,  213  [PMID:33486200] [10.1016/j.ejmech.2021.113157]
2. Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X..  (2020)  Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.,  63  (21.0): [PMID:32539378] [10.1021/acs.jmedchem.0c00502]

Source